The picture of the active site of AChE* that is most widely accepted is that proposed by Wilson and collaborators (Wilson, 1960) , i.e. that there is an 'esteratic site' that becomes acetylated during the reaction with acetylcholine, and also a nearby 'anionic site' that coulombically binds the acetylcholine before the acetylation reaction. Organophosphates and carbamates react in an analogous way, undergoing a binding step followed by a phosphorylation or carbamoylation step. The question that this paper considers is: does the binding step of all substrates and inhibitors involve a common binding site, or are there numerous available binding sites?
Recent work has stressed the importance of hydrophobic interactions in binding organophosphates to acetylcholinesterase (Brestkin et al. 1964; Bracha & O'Brien, 1968a,b) and has pointed to the existence of at least one, rather clearly defined hydrophobic area near the esteratic site. The existence of separate hydrophobic and coulombic binding zones could explain the surprisingly small difference in reactivity of charged and uncharged substrates [such as acetylcholine and its analogue in which the nitrogen atom is replaced by a carbon atom (Adams & Whittaker, 1950) ] and inhibitors [such as Amiton, (C2H50)2P0 .CH2 .CH2 N-(C2H5)2 and its carbon analogue (Bracha & O'Brien, 1968a) ]. However, it would introduce difficulties in attempts to evaluate coulombic contributions by * Abbreviations: AChE, acetylcholinesterase; MCP, 2-chloro-N-(chloroethyl)-N-methyl-2-phenylethylamine.
comparing such charged and uncharged compounds, either by using pairs of such compounds or by examining the pH-dependence of reactivity of ionizable compounds (Wilson & Bergmann, 1950) . Belleau & Tani (1966) described a new type of anti-cholinesterase, and suggested that it irreversibly alkylated the enzyme after attachment to the anionic site. This compound was the NN-dianethyl-2-phenylaziridinium ion, prepared by adding the corresponding 2-chloroethylamine to water. Further, Purdie & McIvor (1966) reported that the enzyme alkylated with NN-dimethyl-2-phenylaziridinium ion, although partially inhibited as far as hydrolysis of acetylcholine was concerned, was 100% activated as far as hydrolysis of indophenyl acetate was concerned. Also the susceptibility to inhibition by Amiton, was decreased or abolished, whereas Sarin, (isoC3H70)(CH3)PO.F, Soman, [(CH3)3C CH(CH3)0](CH3)PO.F, and TEPP, [(C2H5O)2PO]20, were still potent inhibitors. It was suggested that the alkylating agent reacted with the anionic site, and that only Amiton (of the four organophosphates above) bound obligatorily to that site, as did acetylcholine. By contrast, indophenyl acetate, Sarin, Soman and TEPP presumably could react with the esteratic site without requiring to be bound to the anionic site.
The above report appeared to provide a remarkably unambiguous classification of compounds, and implied that two separate binding zones existed on the enzyme, with relatively little overlap. Studies were therefore undertaken of the effect of treatment of AChE with a closely related alkylating agent, MCP, upon susceptibility of the enzyme to inhibition. MCP presumably rearranges spontaneously in water to form the N-(2-chloroethyl)-N-methyl-2-phenylaziridinium ion (Chapman & Triggle, 1963) , which is the chloroethyl analogue of NN-dimethyl-2-phenylaziridinium ion.
METHODS
Bovine erythrocyte AChE (Winthrop Co., New York, N.Y., U.S.A.) or horse plasma butyrylcholinesterase (Worthington Biochemical Corp., Freehold, N.J., U.S.A.) were used. For alkylation with 01 mm-MCP, enzyme in 0-03M-sodium phosphate buffer, pH8, was incubated with an equal volume of0-2 mm-MCP in 5% (w/v) NaCl for 2-25 hr.
For alkylation with 1 OmM-MCP, enzyme and buffer at ten times the original concentration were used and (because of extensive production of acid from hydrolysis of MCP) 2mM-KOH was added to the MCP before mixing, and the system was diluted tenfold after the 2-25hr.
When p-nitrophenyl acetate was the substrate, 1.5 ml.
of an enzyme solution of suitable concentration was preincubated at 250 with 0-5 ml. of 25mM-sodium phosphate buffer, pH8. To it was added 1 ml. of 0-1 mM substrate in 5% (v/v) ethanol, and the reaction was followed at 250 at 402 nm. in a Beckman DK2A recording spectrophotometer. When indophenyl acetate was substrate, to 2 ml. of enzyme solution at 250 was added a freshly mixed solution of0 05 ml.
of substrate solution, 60mM with respect to ethanol, with 1 ml. of the 25mM buffer. The reaction was followed in the same way, but at 625nm. In both cases, inhibitors in 0-5ml. To determine absolute rates of hydrolysis with the spectrophotometric method, indophenol and p-nitrophenol were made by hydrolysis of 4-0mM solutions in M-KOH at room temperature, and adding 001ml. samples at various times to 4 ml. of25 mm-sodium phosphate buffer, pH 8, to measure their extinction. The maximum value was used to determine the molar extinction coefficient.
Other substrates were studied with the Radiometer 
RESULTS
It was first established that treatment of AChE with MCP (as with NN-dimethyl-2-phenylaziridinium ion) greatly decreased its activity toward acetylcholine but enhanced the activity toward indophenyl acetate. An advantage of MCP over NN-dimethyl-2-phenylaziridinium ion was found in that MCP was extremely unstable in water, so that soon after treating the enzyme, the agent was destroyed and could therefore not interfere (e.g. by acting as a competitive inhibitor) in subsequent reactions. The rate of loss of anti-cholinesterase potency (with acetylcholine as substrate) was measured as an index of destruction of MCP. The half-life of the process was 8 5min. at 230 independent of pH (pH6, 7 and 8-2 were studied). The process was very temperature-dependent, for the half-life at 00 and pH8.2 was 730min. The pHindependence and temperature-dependence suggest that the destruction is an SNl reaction (Chapman & Triggle, 1963) . The rate of destruction of inhibitor was also followed by titrating the acid produced by 1 0mM-MCP in phosphate buffer. Fig. 1 shows that at 001mM-MCP, the alkylation (measured by blockage of acetylcholine hydrolysis) proceeded much faster for AChE than for butyrylcholinesterase. The concentration-dependence of alkylation was far less than for more stable compounds (Fig. 2) . Alkylation was slowed by the presence of substrate (Fig. 3) , the protection being less pronounced with butyrylcholinesterase than with AChE.
Other substrates were studied (Table 1) ; alkylation at either of two concentrations of MCP produced an enzyme activated for hydrolysis of indophenyl acetate, and inhibited modestly for that of p-nitrophenyl acetate and much more strongly for that of other substrates, acetylcholine being the most affected.
For three substrates (whose hydrolyses were the most activated, the most inhibited, and a middle type) the question of whether the above effects were due to changes in Km or Vmax. was studied. Organophosphates gave progessive inhibition of the enzyme, from which a bimolecular rate constant kjcouldbecalculatedasdescribedbyAldridge(1950).
CarbFmates caused inhibition that increased until a plateau of inhibition was reached, and this plateau value is reported here. The other inhibitors, being reversible, gave prompt and unchanging inhibition. Tables 3 and 4 show that the potency of all inhibitors was much decreased by alkylation of the enzyme. Of the carbamates and phosphates by far the most affected was Amiton, whose reactivity declined 913-fold even with mildly alkylated enzyme. The inhibitory potency of choline and tetraethylammonium was abolished by alkylation of the enzyme.
The final question was: how does the choice of substrate affect the estimate of reactivity with organophosphates (the phosphorylation reaction occurring, as in all cases in the present study, in the presence of substrate)? The question was studied with the organophosphate most affected by alkyl- ation of the enzyme (Amiton) and that least affected (paraoxon), and by using control enzyme and also that partially alkylated with 0-mm-MCP. In the latter case it was necessary to use ten times as much alkylated enzyme as of control enzyme when acetylcholine was substrate, because of the low reactivity of alkylated enzyme towards acetylcholine.
With control enzyme, similar values for reactivity with paraoxon and Amiton were found with both substrates. Thus in duplicate runs with one enzyme preparation, ki values (defined below and expressed as min.-ll. mole-1) for paraoxon were: 7 4 x 105 and 10-9 X 105 with acetylcholine; 7-9 x 105 and 6.8 x 105 with indophenyl acetate. Similarly for Amiton, kj was 3-3 x 105 and 5.0 x 105 with acetylcholine; 1*3 x 105 and 1 0 x 105 with indophenyl acetate. But when alkylated enzyme was used the substrates gave very different values. Thus for paraoxon the ks with acetylcholine as substrate was 10-1 x 105 and 7.5 x 105 (i.e. the same as with control enzyme), but with indophenyl acetate the values were 0-8 x 105 and 0-75 x 105 (i.e. about one-tenth of that for the control enzyme). With Amiton the effect was even more pronounced: for acetylcholine ki was 1-9 x 105, 2-0 x 105 and 2-3 x 105 (i.e. close to values for control enzyme); whereas with indophenyl acetate the values were 1-3 x 102 and 1-4 x 102 (i.e. about onethousandth of the control values).
The above values show that the estimate of inhibitory potency of phosphates is not affected by choice of substrate in the normal enzyme, but is severely affected in the alkylated enzyme. They also show that a change caused by alkylation in susceptibility to phosphorylation is revealed when indophenyl acetate is substrate, but not when acetylcholine is substrate.
DISCUSSION
The phrase 'strongly alkylated'will be used below to describe the enzyme alkylated by 1 mM-MCP, and ' mildly alkylated' for enzyme alkylated by 0-1 mM-MCP.
For all substrates and for the anti-cholinesterases, the results can be discussed in terms of eqn. (1) 
Effects on 8ubatrate8 and on rever8ible inhibitor8. Strong alkylation of the enzyme virtually abolishes its reactivity towards acetylcholine, or its ability to be inhibited by choline or tetraethylammonium. These three compounds have, like MCP, a quaternary ammonium group; it is suggested that all these compounds combine with a common site, which we may call the a-site, and which could be the same as the 'anionic site'.
It follows that the strongly alkylated enzyme, which has lost 99.7% of its ability to hydrolyse acetylcholine, has 99.7% of its oc-sites blocked. We must now explain why it can hydrolyse six other substrates at 5 % to 161% of control rates (Table 1) ;
it appears that these various responses are reflections of variations in Vmax. but not in Km (Table 2) . The possibility that Ka could be affected by alkylation (i.e. that the affinities, lIK., of the various substrates were differentially effected) can be ruled out on three grounds. (a) It is extremely unlikely that Ka (= klc/k+l) could be changed without changing Ki; the only way this could occur would be by a fortuitous counterbalancing shift in the residual terms of eqn.
(2). (b) Alkylation affects
Vmax., which is computed for saturating conditions when the Ka step is unimportant. (c) One cannot account for the increased rate of hydrolysis of indophenyl acetate by a decrease of affinity. Now Vmax. is a reflection of k2 or k3, whichever is rate-limiting. But the k3 step is identical for all six substrates, for they all yield an acetylated enzyme. Consequently the greatly varying responses in Vmax. must be due to varying effects upon k2, the acetylation step.
The fact that there are two classes of substrates, some whose k2 is decreased and one whose k2 is increased by occupation of the a-site by MCP, is explicable only if one assumes that they bind to two classes ofsite, whichwe may call P and yrespectively; these sites must of course be distinct from the a-site, which is already occupied. A simple hypothesis to explain why f-agents (i.e. those binding to the ,8-site) and y-agents (those binding to the y-site) are differentially affected is that alkylation causes a configurational shift that shifts the catalytic group (usually assumed to be a serine hydroxyl group) away from the fl-site and towards the y-site. Such a shift would of course affect k2 and not Ka or k3, as the experimental findings require.
Effects on carbamate and phosphate inhibitors. No y-agents have been found among the phosphates or carbamates. But clearly Amiton (Table 3) is an a-agent, as judged by its 913-fold decrease in rate constant even on mild alkylation of the enzyme; by contrast, the other phosphates suffer a modest decrease in rate constant and are classified as fl-agents.
Among the carbamates, eserine, carbaryl and 3,5-di-isopropylphenyl methylcarbamate are clearly fl-agents because their reactivity is mildly decreased by alkylation. The other two carbamates lose 95 % of their inhibitory activity on strong alkylation of the enzyme, and so may well be a-agents; and indeed one of the carbamates, neostigmine, has a quaternary ammonium group like the other cx-agents described above.
It is an oddity of those carbamates that are fiagents, that mild alkylation of the enzyme decreases the inhibition by them more than does strong alkylation. The mechanism behind this phenomenon is not clear, but the finding reinforces the distinction between a-and fl-type carbamates.
Some alternative hypotheses. The total blockade, by alkylation of the enzyme, of a-site agents could be interpreted in a way other than that given above. Rather than blocking the a-site, alkylation might shift the a-site relative to the esteratic site so extensively that agents bound to the a-site could not reach the esteratic site with their acylating groups. Such a hypothesis has the virtue of explaining all the results by postulating only one kind of effect. However, the marked protective effect of acetylcholine against alkylation (Fig. 3) is hard to explain by this hypothesis.
There are also alternative ways to explain the activation of hydrolysis of indophenyl acetate by alkylation of the enzyme. (a) Alkylation might reveal additional sites on the enzyme, but it would be remarkable if these should have the same K. as the original sites. (b) Alkylation might prevent formation of hypothetical 'adverse binding'. If so, such adverse binding would have to occur with an affinity very similar to that for the 'successful binding', or else departures from Michaelis-Menten kinetics would be seen, as in the case for acetylcholine where 'adverse binding', involving formation of inactive ES2, is seen only at high substrate concentrations. In addition, the 'adverse' effect would have to show its effect on Vmax. but not on Ki, i.e. the 'adverse' molecule would have to affect k2 but not the affinity of indophenyl acetate for its 'successful-binding' site. (c) The hydrolyses of acetylcholine and indophenyl acetate might be catalysed by entirely different sites, and only the acetylcholine-hydrolysing site might be alkylatable. This alternative is, however, virtually excluded by the finding that in normal AChE, the inhibitory potency (k1) of Amiton or of paraoxon is unaffected by the choice of substrate (acetylcholine or indophenyl acetate) employed for its assay, although the ki of Amiton appeared to be a little greater with acetylcholine than with indophenyl acetate.
Finally, the possible existence of isoenzymes must be considered. Could MCP strongly inhibit a hypothetical acetylcholine-hydrolysing isoenzyme, mildly inhibit a p-nitrophenyl acetate-hydrolysing isoenzyme, and activate a third, indophenyl acetate-hydrolysing, isoenzyme? The possibility that three such isoenzymes exist in the unalkylated enzyme is made very improbable by the fact (stated above) that the rate constants for phosphorylation by paraoxon or Amiton were very similar whether assayed with acetylcholine or with indophenyl acetate.
It is concluded that these alternative hypotheses are relatively implausible.
Relation to reported effects of alkylammonium ions.
A series of papers has described activation effects of tetraethylammonium ions on the reaction of AChE with substrates and inhibitors. Thus tetraethylammonium ions in the 1 mm range activated the hydrolysis of acetyl fluoride threefold (Metzger & Wilson, 1967) , the hydrolysis of dimethylcarbamoyl fluoride 14-fold (Metzger & Wilson, 1963) and the inhibition of AChE by methylsulphonyl fluoride 30-fold (Kitz & Wilson, 1963) . In terms of the hypothesis of the present paper, the implication is that these are all y-site reagents, and that binding of tetraethylammonium ions induces a configurational shift precisely as does alkylation by MCP. The suggestion by Metzger & Wilson (1967) is that 'the binding of the quaternary ammonium ion induces a change at the esteratic site which causes this site to react more rapidly with the acid fluoride'. This explanation is in accord with that proposed above, but is less specific. These findings are complicated by the observations that other alkylammonium ions have quite different effects: for instance, inhibition by methylsulphonyl fluoride is unaffected by tetrapropylammonium ion and blocked by tetrabutylarninonium ion.
Relation to inhibition by excess of8ub8trate. Krupka (1963) has shown that inhibition of acetylcholine hydrolysis by excess of substrate is due to the binding of a molecule of acetylcholine to the acetylated enzyme, with consequent blockage of deacetylation. Since this phenomenon is seen in AChE but not in butyrylcholinesterase (Fig. 3a) , presumably a binding site exists on AChE which either is lacking in butyrylcholinesterase, or is differently located with reference to the locus of deacetylation.
It seemed possible that it was to this special site in AChE that MCP was bound. The possibility is rendered less likely by the observation (Fig. 3 ) that acetylcholine provides maximal protection against MCP at a concentration almost one-tenth of that at which inhibition by excess of substrate occurs. More important, the activity of butyrylcholinesterase in hydrolysis of acetylcholine can be inhibited by MCP (Fig. 1) , although somewhat less readily; and acetylcholine protects the enzyme against such inhibition (Fig. 3) . It therefore appears that the 'extra' binding site of AChE is not involved in binding of MCP.
